Farmakologiska möjligheter vid hjärnskadebehandling. Rätt läkemedelsval kan optimera rehabiliteringsinsatserna
(2007) In Läkartidningen 104(35). p.6-2422- Abstract
- Acquired brain injuries can lead to cognitive, emotional as well as behavioural sequelae and can have a great impact on the affected person and his or her family. Over the last decade, pharmacological treatment has become an important part of brain injury rehabilitation. There is increasing clinical experience of the use of various drugs affecting neurotransmitters and cerebral function, but the scientific evidence is still limited. Within rehabilitation medicine there is also broad knowledge of when after a brain injury drugs can be used and which drugs that are potentially harmful and can negatively impede on post-injury recovery. In this review, we describe some brain injury signs and symptoms that commonly occur during rehabilitation... (More)
- Acquired brain injuries can lead to cognitive, emotional as well as behavioural sequelae and can have a great impact on the affected person and his or her family. Over the last decade, pharmacological treatment has become an important part of brain injury rehabilitation. There is increasing clinical experience of the use of various drugs affecting neurotransmitters and cerebral function, but the scientific evidence is still limited. Within rehabilitation medicine there is also broad knowledge of when after a brain injury drugs can be used and which drugs that are potentially harmful and can negatively impede on post-injury recovery. In this review, we describe some brain injury signs and symptoms that commonly occur during rehabilitation and how pharmacological intervention can be used to treat these signs and symptoms. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/608858
- author
- Lexell, Jan LU ; Lindstedt, Marta ; Sorbo, Ann and Tengvar, Christer
- organization
- alternative title
- Pharmacological possibilities in the treatment of brain injuries. Correct choice of drugs can optimize rehabilitation
- publishing date
- 2007
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Antidepressive Agents: therapeutic use, Antipsychotic Agents: therapeutic use, Brain Injuries: complications, Brain Injuries: drug therapy, Brain Injuries: psychology, Brain Injuries: rehabilitation, Central Nervous System Agents: therapeutic use, Cognition Disorders: drug therapy, Cognition Disorders: etiology, Dopamine Agents: therapeutic use, Epilepsy: drug therapy, Epilepsy: etiology, Humans, Sleep Disorders: etiology, Sleep Disorders: drug therapy, Prognosis, Mental Disorders: etiology, Mental Disorders: drug therapy, Memory Disorders: etiology, Memory Disorders: drug therapy
- in
- Läkartidningen
- volume
- 104
- issue
- 35
- pages
- 6 - 2422
- publisher
- Swedish Medical Association
- external identifiers
-
- scopus:34848820896
- ISSN
- 0023-7205
- language
- Swedish
- LU publication?
- yes
- id
- 21529732-4137-4294-a5b5-e1a530830a38 (old id 608858)
- alternative location
- http://ltarkiv.lakartidningen.se/artNo33801
- date added to LUP
- 2016-04-01 15:27:14
- date last changed
- 2022-01-28 05:27:05
@article{21529732-4137-4294-a5b5-e1a530830a38,
abstract = {{Acquired brain injuries can lead to cognitive, emotional as well as behavioural sequelae and can have a great impact on the affected person and his or her family. Over the last decade, pharmacological treatment has become an important part of brain injury rehabilitation. There is increasing clinical experience of the use of various drugs affecting neurotransmitters and cerebral function, but the scientific evidence is still limited. Within rehabilitation medicine there is also broad knowledge of when after a brain injury drugs can be used and which drugs that are potentially harmful and can negatively impede on post-injury recovery. In this review, we describe some brain injury signs and symptoms that commonly occur during rehabilitation and how pharmacological intervention can be used to treat these signs and symptoms.}},
author = {{Lexell, Jan and Lindstedt, Marta and Sorbo, Ann and Tengvar, Christer}},
issn = {{0023-7205}},
keywords = {{Antidepressive Agents: therapeutic use; Antipsychotic Agents: therapeutic use; Brain Injuries: complications; Brain Injuries: drug therapy; Brain Injuries: psychology; Brain Injuries: rehabilitation; Central Nervous System Agents: therapeutic use; Cognition Disorders: drug therapy; Cognition Disorders: etiology; Dopamine Agents: therapeutic use; Epilepsy: drug therapy; Epilepsy: etiology; Humans; Sleep Disorders: etiology; Sleep Disorders: drug therapy; Prognosis; Mental Disorders: etiology; Mental Disorders: drug therapy; Memory Disorders: etiology; Memory Disorders: drug therapy}},
language = {{swe}},
number = {{35}},
pages = {{6--2422}},
publisher = {{Swedish Medical Association}},
series = {{Läkartidningen}},
title = {{Farmakologiska möjligheter vid hjärnskadebehandling. Rätt läkemedelsval kan optimera rehabiliteringsinsatserna}},
url = {{http://ltarkiv.lakartidningen.se/artNo33801}},
volume = {{104}},
year = {{2007}},
}